Weight Gain After Switch from Efavirenz-Based to Integrase Inhibitor-Based Regimens

BACKGROUND: Integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) offers persons living with HIV a potent new treatment option. Recently, local HIV clinicians noted weight gain in patients who switched from daily, fixed-dose efavirenz/tenofovir disoproxil fumarate/emtricitab...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Main Authors: Norwood, Jamison, Turner, Megan, Bofill, Carmen, Jenkins, Cathy, Bebawy, Sally, Rebeiro, Peter, Hulgan, Todd, Raffanti, Stephen, Haas, David, Sterling, Timothy R, Koethe, John
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631481/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.1094
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares